Who
Lance G. Laing
Chief Science Officer
Company insider
Files Form 4 as: Chief Science Officer, Celcuity.
In numbers
- Trades disclosed
- 45
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 19 Sep 2017
- Last trade
- 14 Aug 2026
- Last filed
- 18 Aug 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 18 Aug 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 14 Aug 2026filed 18 Aug 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code M | $9,8901,000 at $9.89 | filing |
| 2 Jun 2026filed 4 Jun 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,000 at $0.00 | filing |
| 2 Jun 2026filed 4 Jun 2026 | CELC CelcuityBiotechnology | SEC FORM 4 Code M | $9,8901,000 at $9.89 | filing |
| 18 Aug 2025filed 20 Aug 2025 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 13 Feb 2025filed 18 Feb 2025 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,962 at $0.00 | filing |
| 20 Aug 2024filed 26 Aug 2024 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 20 Aug 2024filed 22 Aug 2024 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 13 Feb 2024filed 15 Feb 2024 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,765 at $0.00 | filing |
| 25 Aug 2023filed 29 Aug 2023 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,250 at $0.00 | filing |
| 25 Aug 2023filed 29 Aug 2023 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 16 Feb 2023filed 21 Feb 2023 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,156 at $0.00 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code D | —4,110 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,110 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code D | —1,834 | filing |
| 17 May 2022filed 19 May 2022 | CELC Celcuityoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,834 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.